Encompass Health PE Ratio 2010-2023 | EHC

Current and historical p/e ratio for Encompass Health (EHC) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Encompass Health PE ratio as of April 26, 2024 is 21.25.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Encompass Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-26 82.47 23.77
2023-12-31 66.60 $3.47 19.19
2023-09-30 66.89 $3.50 19.11
2023-06-30 67.29 $3.11 21.64
2023-03-31 53.64 $2.70 19.87
2022-12-31 59.14 $2.70 21.90
2022-09-30 44.61 $2.72 16.40
2022-06-30 54.78 $3.27 16.75
2022-03-31 69.50 $3.91 17.78
2021-12-31 63.53 $3.90 16.29
2021-09-30 72.74 $3.77 19.30
2021-06-30 75.36 $3.11 24.23
2020-12-31 79.30 $2.85 27.83
2020-09-30 62.11 $2.67 23.26
2020-06-30 58.94 $2.96 19.91
2020-03-31 60.66 $3.60 16.85
2019-12-31 65.34 $3.65 17.90
2021-03-31 78.81 $4.00 19.70
2019-09-30 59.45 $3.21 18.52
2019-06-30 59.26 $3.12 19.00
2019-03-31 54.39 $3.12 17.43
2018-12-31 57.20 $2.93 19.52
2018-09-30 72.27 $3.26 22.17
2018-06-30 62.57 $3.04 20.58
2018-03-31 52.63 $2.82 18.66
2017-12-31 45.28 $2.68 16.90
2017-09-30 42.27 $2.75 15.37
2017-06-30 43.90 $2.72 16.14
2017-03-31 38.64 $2.67 14.47
2016-12-31 37.01 $2.58 14.35
2016-09-30 36.20 $2.39 15.15
2016-06-30 34.44 $2.27 15.17
2016-03-31 33.18 $2.07 16.03
2015-12-31 30.51 $1.90 16.06
2015-09-30 33.41 $1.85 18.06
2015-06-30 39.86 $1.85 21.55
2015-03-31 38.22 $2.25 16.99
2014-12-31 32.98 $2.29 14.40
2014-09-30 31.47 $1.54 20.44
2014-06-30 30.42 $1.60 19.01
2014-03-31 30.32 $2.41 12.58
2013-12-31 27.97 $2.41 11.61
2013-09-30 28.79 $3.16 9.11
2013-06-30 23.92 $3.02 7.92
2013-03-31 21.91 $1.79 12.24
2012-12-31 17.54 $1.70 10.32
2012-09-30 19.99 $1.72 11.62
2012-06-30 19.32 $1.82 10.62
2012-03-31 17.01 $1.56 10.91
2011-12-31 14.68 $1.90 7.73
2011-09-30 12.40 $8.60 1.44
2011-06-30 21.81 $8.33 2.62
2011-03-31 20.75 $8.60 2.41
2010-12-31 17.20 $8.24 2.09
2010-09-30 15.95 $1.43 11.15
2010-06-30 15.54 $1.28 12.14
2010-03-31 15.53 $0.70 22.19
2009-12-31 15.59 $0.77 20.25
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.259B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00